Co-administration of IntronA with ribavirin increased the efficacy of IntronA by at least two fold for the treatment of chronic heptatitis C in naïve patients.
IntronA koosmanustamine ribaviriiniga suurendas IntronA efektiivsust kroonilise C- hepatiidiga ja varasema interferoonravi kogemusteta patsientidel vähemalt kaks korda.